KU Hematology & Medical Oncology Review 2019

 

Gastrointestinal
14:39

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and Gemcitabine Adjuvant Therapy

FEATURING Raed Al-Rajabi
  • 839 views
  • August 21, 2019
  • 4
16:20

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best Supportive Care, Nivolumab Alone vs. Combo, and Genetic Targets

FEATURING Raed Al-Rajabi
  • 412 views
  • August 21, 2019
19:12

KU Hematology & Medical Oncology Review 2019

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy in Local-Regional and Neoadjuvant PARPi Therapy in Rectal Cancer

FEATURING Weijing Sun
  • 236 views
  • August 23, 2019
  • 1
18:29

KU Hematology & Medical Oncology Review 2019

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal Cancers: How Much Do We Know?

FEATURING Weijing Sun
  • 313 views
  • August 23, 2019
  • 2